Low awareness of venous thromboembolism among neurosurgical hospitalized patients: a cross-sectional study

[1] Rakesh R(2019)Deep Vein Thrombosis and the Neurosurgical Patient Malays J Med Sci 26 139-616

[2] Azmi A(2020)American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism Blood Adv 19 4693-372

[3] Regunath K(2020)Economic evaluation of rivaroxaban versus enoxaparin for prevention of venous thromboembolism after total knee replacement and total hip replacement: A systematic review Clin Drug Investig 08 715-343

[4] Azman R(2016)The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs Thromb Res 137 3-257

[5] Mun CL(2017)Risk of venous thromboembolism and operative duration in patients undergoing neurosurgical procedures Neurosurgery 05 787-undefined

[6] Tassha H(2017)The postoperative venous thromboembolism (TREVO) study-risk and case mortality by surgical specialty Port J Cardiol 09 609-undefined

[7] Thomas LO(2019)American Society of Hematology 2019 guidelines for management of venous thromboembolism: Prevention of venous thromboembolism in surgical hospitalized patients Blood Adv 23 3898-undefined

[8] Ignacio N(2015)Clinical features and risk factor analysis for lower extremity deep venous thrombosis in Chinese neurosurgical patients J Neurosci Rural Pract 4 471-undefined

[9] Walter A(2009)Prevalence of venous thromboembolism in neurosurgical patients Heart Vessels 24 425-undefined

[10] Asma RK(2011)Venous thromboembolism: Deep venous thrombosis and pulmonary embolism in a neurosurgical population J Neurosurg 114 40-undefined

[1] Rakesh R(2019)Deep Vein Thrombosis and the Neurosurgical Patient Malays J Med Sci 26 139-616

[2] Azmi A(2020)American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism Blood Adv 19 4693-372

[3] Regunath K(2020)Economic evaluation of rivaroxaban versus enoxaparin for prevention of venous thromboembolism after total knee replacement and total hip replacement: A systematic review Clin Drug Investig 08 715-343

[4] Azman R(2016)The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs Thromb Res 137 3-257

[5] Mun CL(2017)Risk of venous thromboembolism and operative duration in patients undergoing neurosurgical procedures Neurosurgery 05 787-undefined

[6] Tassha H(2017)The postoperative venous thromboembolism (TREVO) study-risk and case mortality by surgical specialty Port J Cardiol 09 609-undefined

[7] Thomas LO(2019)American Society of Hematology 2019 guidelines for management of venous thromboembolism: Prevention of venous thromboembolism in surgical hospitalized patients Blood Adv 23 3898-undefined

[8] Ignacio N(2015)Clinical features and risk factor analysis for lower extremity deep venous thrombosis in Chinese neurosurgical patients J Neurosci Rural Pract 4 471-undefined

[9] Walter A(2009)Prevalence of venous thromboembolism in neurosurgical patients Heart Vessels 24 425-undefined

[10] Asma RK(2011)Venous thromboembolism: Deep venous thrombosis and pulmonary embolism in a neurosurgical population J Neurosurg 114 40-undefined